Yarrow Bioscience (YARW)
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases....
- Open
- 39.150
- High
- 41.000
- Low
- 38.700
- Prev. Close
- 39.500
- Volume
- 9.29K
- Turnover
- 371.16K
- Avg Price
- 39.965
- Bid/Ask Ratio
- -40.00%
- Amplitude
- 5.82%
- 52wk High
- 44.276
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.52%
Yarrow Bioscience Analyst Rating
View moreForecast & Rating
Aug 13, 2026Price forecast
$57.0045.22%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 13 at 03:16 PM
Yarrow Bioscience files amended 8-K report on merger exchange ratio update
- Tip Ranks · Aug 13 at 01:25 PM
Analyst Maintains Buy on Yarrow Bioscience, Sees Attractive Risk-Reward with Unchanged $56 Price Target
- PUBT · Aug 13 at 06:00 AM
Yarrow Bioscience Q2 FY26 net loss narrows to $6.51 million; R&D expenses rise to $4.94 million
- TradingView · Aug 5 at 08:16 PM
OrbiMed Advisors Discloses Investment at Yarrow Bioscience with 9.97% Stake
- rttnews · Aug 4 at 03:20 AM
Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE
- benzinga_article · Aug 3 at 09:24 AM
This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
